Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Melanoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage III Lung Non-Small Cell Cancer AJCC v7 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1

Interventions

pembrolizumab 12Cisplatin 11Specimen Handling 9Bevacizumab 7Brachytherapy 6Platinum 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Human Papillomavirus DNA Tests 5Colposcopy 5Carboplatin 5atezolizumab 4Gemcitabine 4Fulvestrant 4Surveys and Questionnaires 3Radiotherapy 3Radiation Dose Hypofractionation 3Radiation 3Drug Therapy 3Blood Specimen Collection 31,2-diaminocyclohexaneplatinum II citrate 3tisotumab vedotin 2palbociclib 2lenvatinib 2Topotecan 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Pemetrexed 2Magnetic Resonance Imaging 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Fluorodeoxyglucose F18 × 90 days × Clear all
NCT02595879 2026-05-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled 22 charts
Gynecologic

Uterine Cervical Neoplasms

NCT04219904 2026-05-20

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
25 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡